Journal of Clinical Medicine
Cure8 research brief
Why This Matters
Reports a rare mesenteric fibroinflammatory complication in a patient with UC who was in remission on vedolizumab, raising a hypothesis about possible associations worth further study.
Who Should Pay Attention
Adult patients with IBD (especially those on biologics), gastroenterologists, and researchers studying IBD complications or biologic safety.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
A 32‑year‑old woman with UC in clinical, endoscopic, and histologic remission on vedolizumab developed symptomatic MP diagnosed by contrast‑enhanced CT. Infectious, neoplastic, and other selected fibroinflammatory causes were excluded; no tissue biopsy confirmation was obtained. The patient improved with prednisone and tamoxifen while continuing vedolizumab.
The authors emphasize that a causal link between MP and either UC activity or vedolizumab cannot be established from this single, non‑biopsied case; they present the observation as hypothesis‑generating and call for more research on MP in IBD and possible relationships with biologic therapies.
Keep In Mind
Single case report without histologic confirmation; narrative review only. Does not establish causality between MP, UC activity, or vedolizumab therapy.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of Clinical Medicine
PublisherMDPI AG
AuthorsCarmen Atodiresei, Alina-Ecaterina Jucan, Georgiana Elena Sârbu +9 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 14, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
IBD Associated With Risk for Genitourinary Cancers
A pooled analysis presented at a medical conference suggests people with IBD—especially ulcerative colitis—may have higher rates of some genitourinary cancers, which could affect discussions about cancer risk and...
Hidradenitis Suppurativa More Prevalent Among Patients With Crohn Disease
Skin disease (hidradenitis suppurativa) may be more common in people with IBD—particularly Crohn disease—and could be linked with more severe intestinal complications. Awareness can prompt coordinated care between...
Large Vessel Vasculitis in IBD Linked to Younger Onset, Distinct Clinical Features
This study suggests LVV can occur in people with IBD at younger ages and with distinct vascular findings, and it may arise even when gut disease is in remission. That matters for awareness, diagnosis, and coordination...